Table I.
Patient characteristics and location at time of non-invasive cardiac stress testing, by test type
| All (N=80,676) |
Nuclear Stress MPI (N=43,700) |
Stress ECHO (N=16,879) |
ETT (N=20,009) |
P-value | |
|---|---|---|---|---|---|
| Age (mean, interquartile range) | 51.5 (46, 57) | 52.1 (47, 57) | 50.8 (45, 56) | 50.7 (45, 56) | <.001 |
| Female (%) | 53 | 54 | 57 | 46 | <.001 |
| Diabetes | 9.9 | 12.0 | 7.0 | 7.9 | <.001 |
| Hypertension | 38.9 | 43.3 | 34.5 | 33.2 | <.001 |
| Hyperlipidemia | 38.1 | 40.7 | 34.1 | 36.0 | <.001 |
| Cerebrovascular Disease | 2.4 | 3.0 | 2.1 | 1.6 | <001 |
| Peripheral Vascular Disease | 1.9 | 2.2 | 1.2 | 1.5 | <.001 |
| Chronic Pulmonary Disease | 7.4 | 8.1 | 6.4 | 6.7 | <.001 |
| Hospital Referral Region* (%) | (% of Total) | (% of Stress Tests in Referral Region)† | <.001 | ||
| Atlanta (2,647) | 3 | 57 | 9 | 34 | |
| Charlotte (914) | 1 | 49 | 34 | 17 | |
| Columbus (1,814) | 2 | 64 | 19 | 17 | |
| Dallas (4,037) | 5 | 32 | 47 | 21 | |
| Denver (1,138) | 1 | 50 | 10 | 40 | |
| East Long Island (1,591) | 2 | 65 | 10 | 25 | |
| Ft. Lauderdale (1,164) | 1 | 79 | 11 | 10 | |
| Ft. Worth (1,684) | 2 | 38 | 39 | 23 | |
| Houston (5,320) | 7 | 61 | 3 | 36 | |
| Kansas City (1,419) | 2 | 38 | 51 | 11 | |
| Los Angeles (962) | 1 | 21 | 31 | 48 | |
| Manhattan (1,375) | 2 | 48 | 19 | 33 | |
| Miami (1,340) | 2 | 87 | 7 | 6 | |
| Milwaukee (1,339) | 2 | 54 | 24 | 21 | |
| Nashville (893) | 1 | 65 | 6 | 29 | |
| Orlando (1,987) | 2 | 73 | 3 | 23 | |
| Phoenix (1,437) | 2 | 50 | 14 | 36 | |
| Raleigh (942) | 1 | 53 | 39 | 8 | |
| St. Louis (2,812) | 4 | 55 | 33 | 12 | |
| Tucson (993) | 1 | 17 | 24 | 59 | |
| ALL OTHERS (44,744) | 56 | 55 | 21 | 24 | |
MPI = myocardial perfusion imaging; ECHO = echocardiography; ETT = exercise treadmill testing.
Data unavailable for 124 patients.
May not sum to 100 due to rounding.